-
SML3691-25MGANAGRELIDE ANALOG A6 (C005B-480767)
Price: $1,074.01List Price: $1,193.35ANAGRELIDE ANALOG A6 -
SML3691-5MGANAGRELIDE ANALOG A6 (C005B-480768)
Price: $335.59List Price: $372.88ANAGRELIDE ANALOG A6 -
1034750-25MGANAGRELIDE RELATED COMPOUND B UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,427.57List Price: $2,697.30This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1034771-25MGANAGRELIDE RELATED COMPOUND C UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,499.50List Price: $2,777.22This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
189511-10MGAUTOTAXIN INHIBITOR II HA13 1PC X 10MG
Price: $347.99List Price: $386.65A thiazolidinedione that is designed to target the ATX active site thr210 with a boronic moiety and shown to potently inhibit ATX lysoPLD activity (IC 50 ~28 nM using recombinant human ATX or human plasma) in a reversible manner with a mixed-type -
A5327-10 mgPDE3 inhibitor used to treat essential thrombocytosis and other chronic myeloproliferative disorders. It suppresses megakaryocytopoiesis and inhibits thombopoietin-mediated cell differentiation. (C003B-255212)
Price: $453.00List Price: $503.33Anagrelide is an imidazoquinazoline anti-platelet compound that inhibits platelet aggregation at high doses and decreases platelet activity at low doses. Anagrelide inhibits phosphodiesterase III (PDE3). -
A5327-100 mgPDE3 inhibitor used to treat essential thrombocytosis and other chronic myeloproliferative disorders. It suppresses megakaryocytopoiesis and inhibits thombopoietin-mediated cell differentiation. (C003B-256004)
Price: $1,805.12List Price: $2,005.69Anagrelide is an imidazoquinazoline anti-platelet compound that inhibits platelet aggregation at high doses and decreases platelet activity at low doses. Anagrelide inhibits phosphodiesterase III (PDE3). -
A5327-25 mgPDE3 inhibitor used to treat essential thrombocytosis and other chronic myeloproliferative disorders. It suppresses megakaryocytopoiesis and inhibits thombopoietin-mediated cell differentiation. (C003B-256079)
Price: $919.71List Price: $1,021.90Anagrelide is an imidazoquinazoline anti-platelet compound that inhibits platelet aggregation at high doses and decreases platelet activity at low doses. Anagrelide inhibits phosphodiesterase III (PDE3).



